NCT01719926View on ClinicalTrials.gov

Phase I Platinum Based Chemotherapy Plus Indomethacin

PHASE1CompletedINTERVENTIONAL
Enrollment

13

Participants

Timeline

Start Date

September 30, 2012

Primary Completion Date

August 31, 2017

Study Completion Date

August 31, 2017

Conditions
Colorectal NeoplasmsEsophageal NeoplasmsOvarian Neoplasms
Interventions
DRUG

Indomethacin

3 times per day from 2 days before until 5 days after chemotherapy. Escalating dosage each cohort.

Trial Locations (4)

3813TZ

Meander Medisch Centrum, Amersfoort

1066 CX

the Netherlands Cancer Institute, Amsterdam

3584CX

UMC Utrecht, Utrecht

CH-6500

Oncology Institute of Southern Switzerland, Bellinzona

All Listed Sponsors
lead

UMC Utrecht

OTHER

NCT01719926 - Phase I Platinum Based Chemotherapy Plus Indomethacin | Biotech Hunter | Biotech Hunter